Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 1 | uM | 8 | 156.25 | 28.44 | 158.00 | 89.50 | 1.7654 | 1.8200 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 28.44 | 133.00 | 89.50 | 1.4860 | 1.5412 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 93.00 | 89.50 | 1.0391 | 1.0469 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 28.44 | 61.00 | 89.50 | 0.6816 | 0.5863 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 66.00 | 89.50 | 0.7374 | 0.6636 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 53.00 | 89.50 | 0.5922 | 0.4570 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 52.00 | 89.50 | 0.5810 | 0.4403 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 57.00 | 89.50 | 0.6369 | 0.5225 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 156.25 | 28.44 | 113.00 | 89.50 | 1.2626 | 1.3027 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 91.00 | 89.50 | 1.0168 | 1.0202 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 163.00 | 89.50 | 1.8212 | 1.8737 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 55.00 | 89.50 | 0.6145 | 0.4900 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 101.00 | 89.50 | 1.1285 | 1.1516 |
| BT-20 | Erlotinib | 10 | uM | 8 | 156.25 | 28.44 | 87.00 | 89.50 | 0.9721 | 0.9660 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 126.00 | 89.50 | 1.4078 | 1.4594 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 28.44 | 102.00 | 89.50 | 1.1397 | 1.1645 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 156.25 | 28.44 | 135.00 | 89.50 | 1.5084 | 1.5642 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 156.25 | 28.44 | 116.00 | 89.50 | 1.2961 | 1.3395 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 28.44 | 141.00 | 89.50 | 1.5754 | 1.6325 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 156.25 | 28.44 | 45.00 | 89.50 | 0.5028 | 0.3198 |
| BT-20 | Linsitinib | 10 | uM | 8 | 156.25 | 28.44 | 128.00 | 89.50 | 1.4302 | 1.4830 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 113.00 | 89.50 | 1.2626 | 1.3027 | |
| BT-20 | Lapatinib | 1 | uM | 8 | 156.25 | 28.44 | 77.00 | 89.50 | 0.8603 | 0.8261 |
| BT-20 | Lapatinib | 10 | uM | 8 | 156.25 | 28.44 | 33.00 | 89.50 | 0.3687 | 0.0941 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 115.00 | 89.50 | 1.2849 | 1.3273 |